EVALUATION OF ONCE-DAILY TOBRAMYCIN DOSING GUIDELINES IN PEDIATRIC CYSTIC FIBROSIS PATIENTS IN A LARGE TEACHING HOSPITAL

被引：0
|
作者：
Piechowski, K. [1 ]
Biondo, L. R. [2 ]
Maynor, L. [1 ]
机构：
[1] W Virginia Univ, Sch Pharm, Morgantown, WV 26506 USA
[2] West Virginia Univ Hosp, Morgantown, WV USA
来源：
PEDIATRIC PULMONOLOGY | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
下载
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF A ONCE-DAILY NETILMICIN REGIMEN IN THE TREATMENT OF CYSTIC-FIBROSIS
    SMITH, DL
    STABLEFORTH, DE
    GEDDES, AM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (01) : 191 - 193
  • [42] Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity
    Olsen, KM
    Rudis, MI
    Rebuck, JA
    Hara, J
    Gelmont, D
    Mehdian, R
    Nelson, C
    Rupp, ME
    CRITICAL CARE MEDICINE, 2004, 32 (08) : 1678 - 1682
  • [43] Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients
    van Koningsbruggen-Rietschel, S.
    Heuer, H. E.
    Merkel, N.
    Posselt, H. G.
    Staab, D.
    Sieder, C.
    Ziegler, J.
    Krippner, F.
    Rietschel, E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 711 - 717
  • [44] The authors respond: Once-daily tobramycin monotherapy in cystic fibrosis - To Dr. Joseph R Marino
    Master, V
    PEDIATRIC PULMONOLOGY, 2002, 33 (05) : 407 - 407
  • [45] Once-daily tobramycin in cystic fibrosis: Better clinical outcome than tid but more resistance development?
    Burkhardt, O
    Madabushi, R
    Lehmann, C
    Welte, T
    Derendorf, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1072 - 1072
  • [46] THERAPEUTIC DRUG MONITORING OF ONCE-DAILY TOBRAMYCIN IN CYSTIC FIBROSIS ADULTS HOSPITALIZED IN A TERTIARY PULMONARY CENTER
    Lachance, A.
    Cloutier, I
    Vachon, A.
    Methot, J.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 332 - 332
  • [47] Population Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis
    Praet, Antonin
    Bourguignon, Laurent
    Vetele, Florence
    Breant, Valentine
    Genestet, Charlotte
    Dumitrescu, Oana
    Doleans-Jordheim, Anne
    Reix, Philippe
    Goutelle, Sylvain
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [48] Determination of Tobramycin Pharmacokinetics in Burn Patients to Evaluate the Potential Utility of Once-Daily Dosing in this Population
    Vella, Diane
    Walker, Sandra A. N.
    Walker, Scott E.
    Daneman, Nick
    Simor, Andrew
    JOURNAL OF BURN CARE & RESEARCH, 2014, 35 (04): : E240 - E249
  • [49] Tobramycin Once- vs Thrice-Daily for Elective Intravenous Antipseudomonal Therapy in Pediatric Cystic Fibrosis Patients
    Riethmueller, J.
    Ballmann, M.
    Schroeter, T. W.
    Franke, P.
    von Butler, R.
    Claass, A.
    Junge, S.
    Doering, G.
    Stern, M.
    INFECTION, 2009, 37 (05) : 424 - 431
  • [50] Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients
    J. Riethmueller
    M. Ballmann
    T. W. Schroeter
    P. Franke
    R. von Butler
    A. Claass
    S. Junge
    G. Doering
    M. Stern
    Infection, 2009, 37 : 424 - 431
12345